Vigilant diabetes management companion launches in the U.S.

Vigilant

InSpark Technologies has made its Vigilant app available to users in the United States, allowing them to monitor and analyze patient blood glucose data. The application provides users with feedback about daily patterns of highs, lows, glucose variability (frequent swings) and test frequency, as well as patterns indicative of increased risk of severe hypoglycemia in the next 24 hours. It can also connect with the Accu-Chek Aviva Connect blood glucose meter to enable wireless acquisition of the data when user is testing.

“We couldn’t be more excited about bringing Vigilant to the diabetes community,” Erik Otto, President and Co-Founder of InSpark, who also has Type 1 diabetes, said in a statement. “Now you don’t have to be encumbered by looking at detailed data logs and charts. Vigilant can analyze your data to give important insights about upcoming periods of risk when you test, because we know that is when you are making diabetes management decisions.”

Beyond the app itself, InSpark also provides a dedicated web-based service for clinicians and caregivers, enabling them to know about their patient or loved one’s patterns and risks, at a glance.

Vigilant is a product of well over 10 years of work by leading scientists and engineers at the University of Virginia and InSpark Technologies to develop pattern recognition tools that can help with daily diabetes management decisions. There are over 20 peer-reviewed medical journal articles that support the scientific basis of InSpark’s pattern recognition algorithms, their evaluation in large and diverse diabetes population datasets, or report on clinical studies where algorithmic feedback is given to users.

Hypoglycemia results in 280,000 emergency room visits a year in the United States, and is one of the greatest fears for people using Insulin.